MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML
Author:
Publisher
Springer Nature Switzerland
Link
https://link.springer.com/content/pdf/10.1007/978-3-031-62731-6_15
Reference80 articles.
1. Roloff GW, Odenike O, Bajel A, Wei AH, Foley N, Uy GL (2022) Contemporary approach to acute myeloid leukemia therapy in 2022. Am Soc Clin Oncol Educ Book 42:1–16. https://doi.org/10.1200/EDBK_349605
2. Hofmann S, Schubert M-L, Wang L, He B, Neuber B, Dreger P, Müller-Tidow C, Schmitt M (2019) Chimeric antigen receptor (CAR) T cell therapy in acute myeloid leukemia (AML). J Clin Med 8:200. https://doi.org/10.3390/jcm8020200
3. Assi SA, Imperato MR, Coleman DJL, Pickin A, Potluri S, Ptasinska A, Chin PS, Blair H, Cauchy P, James SR, Zacarias-Cabeza J, Gilding LN, Beggs A, Clokie S, Loke JC, Jenkin P, Uddin A, Delwel R, Richards SJ, Raghavan M, Griffiths MJ, Heidenreich O, Cockerill PN, Bonifer C (2019) Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat Genet 51:151–162. https://doi.org/10.1038/s41588-018-0270-1
4. De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6:e441. https://doi.org/10.1038/bcj.2016.50
5. Beug H, von Kirchbach A, Döderlein G, Conscience JF, Graf T (1979) Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18:375–390. https://doi.org/10.1016/0092-8674(79)90057-6
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3